S&P 5007,533.77▼0.5% Nasdaq25,881.95▼1.5% Dow52,552.97▼0.2% Russell 2K2,974.57▼0.1% 10-Yr4.57%+2bp VIX16.73+1.06 WTI$79.00▼0.8% Gold$3,981.40▼1.6% EUR/USD1.145▼0.2% BTC$64,048▲0.4% Nikkei68,752▲1.5%
At close · Thu, Jul 16, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›Merck seen backing a takeover, as its genomics target…

Merck seen backing a takeover, as its genomics target slips

Friday, July 17, 2026 · Written up by our desk · M&A & Deals

Yahoo Finance reports that Merck is reportedly taking a more active role in a takeover battle.

The same report says the target’s genomics stock reversed course after the news, indicating market sensitivity around the deal dynamics.

← Newer storyNasdaq and AI stocks weigh on US shares in weekly review

More like this

US MarketsPureCycle alliance targets 2027 launch for recycled BOPP films in Japan
US MarketsFAA restarts Boeing airworthiness certificates for 737 MAX and 787
US MarketsX and major music publishers agree to dismiss copyright lawsuits
US MarketsEli Lilly stock holds support as $3 billion deal closes in
US MarketsAnthropic enters early talks with Meta over access to compute power

Sources

Yahoo FinanceMerck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.